Revolve Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Revolve Wealth Partners's AMGN Position: Q2 2026 in Review
Revolve Wealth Partners reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $124K and leaving 12,937 shares worth $4.68M. The position accounts for 0.49% of the portfolio, ranked #39.
Revolve Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.42M in Q4 2021. 1,292 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Revolve Wealth Partners held 12,937 shares of Amgen worth $4.68M as of Q2 2026.
- Revolve Wealth Partners sold 361 Amgen shares in Q2 2026, an estimated $124K.
- Amgen made up 0.49% of Revolve Wealth Partners's portfolio in Q2 2026, its #39 holding.
- Revolve Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Revolve Wealth Partners's Amgen position peaked at $6.42M in Q4 2021.
- 1,292 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.